Catalio Capital Management Team
Photo of João Amorim, Analyst at Catalio Capital Management
João Amorim
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Benjamin Bell, Analyst at Catalio Capital Management
Benjamin Bell
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital Management
George C. Petrocheilos
Catalio Capital Management·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Robotics (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Washington, D.C. (Other Lists), Investors in Cybersecurity (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed)
Photo of Nicholas von Guionneau, Catalio Capital Management
Nicholas von Guionneau
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Photo of Matthew Hobson, Principal at Catalio Capital Management
Matthew Hobson
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Chau Khuong, General Partner at Catalio Capital Management
Chau Khuong
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Kenan Turnacioglu, General Partner at Catalio Capital Management
Kenan Turnacioglu
Sweet spot: $25K
Range: $5K - $50K
Investors in New York City
Photo of Tom V. Brooks, General Partner at Catalio Capital Management
Tom V. Brooks
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denver (CO), Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in EnergyTech (Series A), Investors in EnergyTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Colorado / Utah (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital Management
R. Jacob Vogelstein
Catalio Capital Management·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.), Investors in Baltimore (MD), Investors in Bethesda
Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in Washington, D.C. (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B)